Jonas Wohlfarth

Wuerzburg, BY, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Targeting Langerhans cells using a modular mannosylated nucleic acid-based vaccine platform.

Targeting Langerhans cells using a modular mannosylated nucleic acid-based vaccine platform.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: July 30, 2025

Immunotherapy of malignant melanoma using T cell-activating microbeads.

Immunotherapy of malignant melanoma using T cell-activating microbeads.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Published: July 15, 2025

Susceptibility of Melanoma Cells to Targeted Therapy Correlates with Protection by Blood Neutrophils.

Susceptibility of Melanoma Cells to Targeted Therapy Correlates with Protection by Blood Neutrophils.

Journal: Cancers

Published: April 08, 2024

Loss of p14 diminishes immunogenicity in melanoma via non-canonical Wnt signaling by reducing the peptide surface density.

Loss of p14 diminishes immunogenicity in melanoma via non-canonical Wnt signaling by reducing the peptide surface density.

Journal: Molecular oncology

Published: January 03, 2024

Inhibition of p90 ribosomal S6 kinases disrupts melanoma cell growth and immune evasion.

Inhibition of p90 ribosomal S6 kinases disrupts melanoma cell growth and immune evasion.

Journal: Journal of experimental & clinical cancer research : CR

Published: May 04, 2023

Blood Eosinophils Are Associated with Efficacy of Targeted Therapy in Patients with Advanced Melanoma.

Blood Eosinophils Are Associated with Efficacy of Targeted Therapy in Patients with Advanced Melanoma.

Journal: Cancers

Published: March 31, 2022

MHC class-I downregulation in PD-1/PD-L1 inhibitor refractory Merkel cell carcinoma and its potential reversal by histone deacetylase inhibition: a case series.

MHC class-I downregulation in PD-1/PD-L1 inhibitor refractory Merkel cell carcinoma and its potential reversal by histone deacetylase inhibition: a case series.

Journal: Cancer immunology, immunotherapy : CII

Published: September 10, 2018

Allergy-Inducing Chromium Compounds Trigger Potent Innate Immune Stimulation Via ROS-Dependent Inflammasome Activation.

Allergy-Inducing Chromium Compounds Trigger Potent Innate Immune Stimulation Via ROS-Dependent Inflammasome Activation.

Journal: The Journal of investigative dermatology

Published: June 20, 2016

Showing 1-8 of 8

Last Updated: 09/26/2026